Management of patients with myoclonus: available therapies and the need for an evidence-based approach

Joke M. Dijk, Marina A. J. Tijssen

Research output: Contribution to journalReview articleAcademicpeer-review

64 Citations (Scopus)

Abstract

Myoclonus is a hyperkinetic movement disorder characterised by quick and involuntary jerks. Therapy should focus on cure of an underlying disorder; however, symptomatic treatment is often needed when treatment of an underlying cause is impossible or ineffective. The appropriate treatment for a specific type of myoclonus is based on the classification of the anatomical origin of the myoclonus: cortical, subcortical, spinal, or peripheral. We outline criteria for classification and present an overview of the available therapeutic options for the different types of myoclonus. Because of a generally low level of evidence, therapeutic options mainly rely on small observational studies and expert opinion. For an evidence-based approach in the future, randomised controlled trials of symptomatic therapies for myoclonus in homogeneous patient groups are needed
Original languageEnglish
Pages (from-to)1028-1036
JournalLancet neurology
Volume9
Issue number10
DOIs
Publication statusPublished - 2010

Cite this